84
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Risk factors associated with elevated blood cytomegalovirus pp65 antigen levels in patients with autoimmune diseases

, , , &
Pages 345-350 | Received 01 Feb 2012, Accepted 03 Apr 2012, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shunya Kaneshita, Takashi Kida, Isao Yokota, Hidetake Nagahara, Takahiro Seno, Makoto Wada, Masataka Kohno & Yutaka Kawahito. (2020) Risk factors for cytomegalovirus disease with cytomegalovirus re-activation in patients with rheumatic disease. Modern Rheumatology 30:1, pages 109-115.
Read now

Articles from other publishers (19)

Yuki Shiina, Mayuko Kawabe, Yohei Suehiro, Haruki Katsumata, Yasuyuki Nakada, Akimitsu Kobayashi, Izumi Yamamoto, Fumihiko Urabe, Jun Miki, Hiroki Yamada, Takahiro Kimura, Yudo Tanno, Ichiro Ohkido, Hiroyasu Yamamoto & Takashi Yokoo. (2023) Peripheral Blood Absolute Lymphocyte Count as a Predictor of Cytomegalovirus Infection in Kidney Transplant Recipients. Transplantation Proceedings.
Crossref
Tianyu Zhang, Zhongxun Yu, Sihao Gao, Yuelun Zhang, Changyan Wang, Shan Jian, Lin Wang, Lijuan Gou, Ji Li, Mingsheng Ma & Hongmei Song. (2023) Clinical phenotypes and prognosis of cytomegalovirus infection in the pediatric systemic lupus erythematosus: a longitudinal analysis. Pediatric Rheumatology 21:1.
Crossref
Tatsuya Shimada, Misako Higashida-Konishi, Keisuke Izumi, Satoshi Hama, Tatsuhiro Oshige, Hisaji Oshima & Yutaka Okano. (2022) Risk factors associated with cytomegalovirus reactivation in patients receiving immunosuppressive therapy for rheumatic diseases: a retrospective study. Scientific Reports 12:1.
Crossref
Hideyuki Ogata, Nobumasa Aoki, Kei Nagano, Mariko Hakamata, Yuuki Bamba, Satoshi Shibata, Takeshi Koizumi, Yasuyoshi Ohshima, Satoshi Watanabe, Hiroshi Moro, Toshiyuki Koya & Toshiaki Kikuchi. (2022) Factors associated with cytomegalovirus antigenemia in patients with rheumatic disease: A retrospective study. Journal of Infection and Chemotherapy 28:11, pages 1471-1477.
Crossref
Yosuke Iwatani, Nobuyuki Amemiya, Hirohiko Nokiba, Mayuko Yamazaki, Hidekazu Sugiura & Kosaku Nitta. (2021) Risk factors for cytomegalovirus reactivation in patients with kidney disease under immunosuppressive therapy. Clinical and Experimental Nephrology 26:1, pages 22-28.
Crossref
Qingluan Yang, Zhe Zhou, Xuefang Yang, Yuming Chen, Aiping Liu, Bingyan Zhang, Lingyun Shao, Jianming Zheng & Wenhong Zhang. (2021) Latent Cytomegalovirus Reactivation in Patients With Liver Failure: A 10-Year Retrospective Case-Control Study, 2011-2020. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Akiko Sekiguchi, Yuta Inoue, Sahori Yamazaki, Akihiko Uchiyama, Yukie Endo, Osamu Ishikawa & Sei‐ichiro Motegi. (2020) Demographic and clinical characteristics of cytomegalovirus reactivation in dermatomyositis. The Journal of Dermatology 47:8, pages 876-881.
Crossref
Rebeka Paulo Santos, Edgard Torres dos Reis-Neto & Marcelo Medeiros Pinheiro. (2019) Incidence of Cytomegalovirus Antigenemia in patients with autoimmune rheumatic diseases: a 3-year retrospective study. Advances in Rheumatology 59:1.
Crossref
Hui Min Charlotte Choo, Wen Qi Cher, Yu Heng Kwan & Warren Weng Seng Fong. (2019) Risk factors for cytomegalovirus disease in systemic lupus erythematosus (SLE): a systematic review. Advances in Rheumatology 59:1.
Crossref
Georgios Efthymiou, Efthymios Dardiotis, Christos Liaskos, Emmanouela Marou, Thomas Scheper, Wolfgang Meyer, Alexandros Daponte, Dimitrios Daoussis, Georgios Hadjigeorgiou, Dimitrios P. Bogdanos & Lazaros I. Sakkas. (2019) A comprehensive analysis of antigen-specific antibody responses against human cytomegalovirus in patients with systemic sclerosis. Clinical Immunology 207, pages 87-96.
Crossref
Jingtao Cui, Wenjuan Yan, Hongjie Xie, Shaoxia Xu, Qiaofeng Wang, Weihong Zhang & Anping Ni. (2019) Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: A 10−year single hospital experience. PLOS ONE 14:8, pages e0221793.
Crossref
Yan Li, Limin Ren, Xu Liu, Xiaotao Zhao, Fanlei Hu & Zhanguo Li. (2019) Pulse corticosteroids in treatment of rheumatic disease concomitant with cytomegalovirus infection. International Journal of Rheumatic Diseases 22:4, pages 583-591.
Crossref
Charles Cassius, Hélène Le Buanec, Jean-David Bouaziz & Reyhan Amode. (2019) Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome. Journal of Immunology Research 2019, pages 1-15.
Crossref
Cynthia C Lim, Yu Tzu Tung, Ban Hock Tan, Puay Hoon Lee, Irene Mok, Lynette Oon, Kwai Peng Chan & Jason CJ Choo. (2018) Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapy. Nephrology 23:7, pages 676-681.
Crossref
Katia Lino, Natalia Trizzotti, Fabiana Rabe Carvalho, Rachel Ingrid Cosendey, Cintia Fernandes Souza, Evandro Mendes Klumb, Andrea Alice Silva & Jorge Reis Almeida. (2018) Pp65 antigenemia and cytomegalovirus diagnosis in patients with lupus nephritis: report of a series.. Brazilian Journal of Nephrology 40:1, pages 44-52.
Crossref
M. Martin, A. Guffroy, X. Argemi & T. Martin. (2017) Lupus érythémateux systémique et lymphopénie : aspects cliniques et physiopathologiques. La Revue de Médecine Interne 38:9, pages 603-613.
Crossref
Rodney P. Jones. 2015. Infection and Autoimmunity. Infection and Autoimmunity 319 357 .
Raquel Faria, Cláudia Pereira, Rute Alves, Teresa Mendonça, Fátima Farinha & Carlos Vasconcelos. 2015. Infection and Autoimmunity. Infection and Autoimmunity 251 277 .
J Zhang, Y Dou, Z Zhong, J Su, D Xu, F Tang, X Zhang, Y Zhao, X Zeng, F Zhang & X You. (2014) Clinical characteristics and therapy exploration of active human cytomegalovirus infection in 105 lupus patients. Lupus 23:9, pages 889-897.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.